亚太地区快速检测试剂盒市场预测至 2030 年 - 区域分析 - 按类型(快速抗原检测、快速抗体检测等)、产品(非处方快速检测试剂盒和专业快速检测试剂盒)、技术(横向流动测定、固相、凝集、免疫斑点测定和基于细胞成分)、应用(血糖检测、传染病检测、怀孕和生育、心脏代谢检测等)和最终用户(医院和诊所、家庭护理、诊断中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 170    |    Report Code: BMIRE00030382    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Rapid Test Kit Market
2022 年亚太地区快速检测试剂盒市场价值为 38.3699 亿美元,预计到 2030 年将达到 59.3528 亿美元;预计 2022 年至 2030 年的复合年增长率为 5.6%。

对 PCR 技术的偏好日益增加推动了亚太地区快速检测试剂盒市场的发展

近年来,PCR 等分子方法已发展成为更有效的诊断工具,因为它们有助于准确诊断多种传染病。大多数流行的分子测试使用逆转录聚合酶链反应 (RT-PCR)。该技术提供可重复的结果,可在不同的实验室之间进行比较,因此被全世界接受。制造商参与了新的 PCR 开发。

例如,GeneSoC 是一种最近开发的系统,其中 PCR 反应溶液在多个预热区域上往复驱动,并封装在极薄流道内的芯片上。 GeneSoC 可用于多重实时 PCR,可同时检测 3 个荧光通道。它被视为检测甲型和乙型流感病毒的极佳替代诊断技术,因为它可在约 16 分钟内完成实时 RT-PCR 反应。PCR 技术也在新兴国家被广泛接受和使用。根据世界卫生组织 2016 年关于发展中国家建立 PCR 实验室的报告,世卫组织为所有 11 个东南亚国家建立 PCR 实验室提供必要的技术援助。这些设施根据需要采用了不同的 PCR 技术,例如 RT-PCR、多重 PCR、实时 PCR、原位 PCR 和 dPCR。由于该工具可以实现简单、快速和高度特异性的筛查,PCR 技术在临床微生物学、病毒学、寄生虫学、生物技术和相关领域的应用也在增加。因此,在预测期内,PCR 作为诊断和临床工具的日益增长的偏好预计将为快速检测试剂盒市场提供丰厚的机会。

亚太快速检测试剂盒市场概览

世界卫生组织认为 HIV 自我检测 (HIVST) 是诊断实验室进行的标准 HIV 检测的合法替代方案。在过去五年中,中国的医疗保健部门和当局一直努力逐步提高 HIVST 的使用范围。借助 HIVST,可以进一步提高 HIV 检测的覆盖率,以便在感染 HIV 但不知道自己感染了 HIV 的个体中识别病情。中国政府强调男同性恋中 HIVST 感染率的快速上升。中国国务院于 2017 年发布了艾滋病防治“十三五”规划(2017-2022 年),据该部称,中国一直在探索通过在药店和网上销售 HIVST 试剂盒来促进艾滋病毒自我检测的策略。

亚太快速检测试剂盒市场收入及 2030 年预测(百万美元)

亚太快速检测试剂盒市场细分

亚太快速检测试剂盒市场根据类型、产品、技术、应用、最终用户和国家进行细分。根据类型,亚太快速检测试剂盒市场细分为快速抗原检测、快速抗体检测和其他。快速抗原检测部分在 2022 年占据了最大的市场份额。

就产品而言,亚太快速检测试剂盒市场分为非处方快速检测试剂盒和专业快速检测试剂盒。非处方快速检测试剂盒部分在 2022 年占据了更大的市场份额。

按技术划分,亚太快速检测试剂盒市场细分为横向流动测定、固相、凝集、免疫斑点测定和基于细胞成分。横向流动测定部分在 2022 年占据了最大的市场份额。

根据应用,亚太快速检测试剂盒市场分为血糖检测、传染病检测、妊娠和生育、心脏代谢检测等。血糖检测部分在 2022 年占据了最大的市场份额。

就最终用户而言,亚太快速检测试剂盒市场细分为医院和诊所、家庭护理、诊断中心等。医院和诊所部分在 2022 年占据了最大的市场份额。

根据国家/地区,亚太快速检测试剂盒市场细分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。 2022 年,中国占据了亚太地区快速检测试剂盒市场的主导地位。

F. Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、广州万孚生物科技有限公司、Denka Co Ltd、Abbott Laboratories、SD Biosensor Inc、Premier Medical Corp Pvt Ltd、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA 和 Beckman Coulter Inc 是亚太地区快速检测试剂盒市场的一些领先企业。

Asia Pacific Rapid Test Kit Strategic Insights

Strategic insights for Asia Pacific Rapid Test Kit involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-rapid-test-kit-market-strategic-framework.webp
Get more information on this report

Asia Pacific Rapid Test Kit Report Scope

Report Attribute Details
Market size in 2022 US$ 3,836.99 Million
Market Size by 2030 US$ 5,935.28 Million
Global CAGR (2022 - 2030) 5.6%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 类型
  • 快速抗原检测
  • 快速抗体检测
By 产品
  • 非处方快速检测试剂盒和专业快速检测试剂盒
By 应用
  • 血糖检测
  • 传染病检测
  • 妊娠及生育
  • 心脏代谢检测
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Get more information on this report

    Asia Pacific Rapid Test Kit Regional Insights

    The regional scope of Asia Pacific Rapid Test Kit refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-rapid-test-kit-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Rapid Test Kit Market

    1. F. Hoffmann-La Roche Ltd
    2. Becton Dickinson and Co
    3. ARKRAY Inc
    4. Fujirebio Europe NV
    5. bioMerieux SA
    6. Cepheid
    7. Meril Life Sciences Pvt Ltd
    8. QIAGEN NV
    9. OraSure Technologies Inc
    10. Guangzhou Wondfo Biotech Co Ltd
    11. Denka Co Ltd
    12. Abbott Laboratories
    13. Bio-Rad Laboratories Inc
    14. Hologic Inc
    15. SD Biosensor Inc
    16. Premier Medical Corp Pvt Ltd
    17. DiaSorin SpA
    18. Beckman Coulter Inc

    Frequently Asked Questions
    How big is the Asia Pacific Rapid Test Kit Market?

    The Asia Pacific Rapid Test Kit Market is valued at US$ 3,836.99 Million in 2022, it is projected to reach US$ 5,935.28 Million by 2030.

    What is the CAGR for Asia Pacific Rapid Test Kit Market by (2022 - 2030)?

    As per our report Asia Pacific Rapid Test Kit Market, the market size is valued at US$ 3,836.99 Million in 2022, projecting it to reach US$ 5,935.28 Million by 2030. This translates to a CAGR of approximately 5.6% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Rapid Test Kit Market report typically cover these key segments-

  • 类型 (快速抗原检测, 快速抗体检测)
  • 产品 (非处方快速检测试剂盒和专业快速检测试剂盒)
  • 应用 (血糖检测, 传染病检测, 妊娠及生育, 心脏代谢检测)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Rapid Test Kit Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Rapid Test Kit Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Rapid Test Kit Market?

    The Asia Pacific Rapid Test Kit Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Denka Co Ltd
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • SD Biosensor Inc
  • Premier Medical Corp Pvt Ltd
  • DiaSorin SpA
  • Beckman Coulter Inc
  • Who should buy this report?

    The Asia Pacific Rapid Test Kit Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Rapid Test Kit Market value chain can benefit from the information contained in a comprehensive market report.